Have a feature idea you'd love to see implemented?
Let us know!
ICAD Icad Inc
Price (delayed)
$1.83
Market cap
$48.57M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.11
Enterprise value
$30.19M
iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection
Highlights
The debt has decreased by 19% YoY and by 12% from the previous quarter
The gross profit has increased by 13% year-on-year
Icad's quick ratio has soared by 78% YoY but it has decreased by 4.8% from the previous quarter
The net income has soared by 73% YoY but it has contracted by 19% from the previous quarter
The equity has contracted by 5% YoY and by 5% from the previous quarter
Key stats
What are the main financial stats of ICAD
Market
Valuations
Earnings
Shares outstanding
26.54M
Market cap
$48.57M
Enterprise value
$30.19M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.65
Price to sales (P/S)
2.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.59
Revenue
$18.94M
Gross profit
$16.29M
Net income
-$2.71M
EBIT
-$2.67M
EBITDA
-$1.94M
Free cash flow
-$4.92M
Per share
Balance sheet
Liquidity
EPS
-$0.11
EPS diluted
-$0.11
Free cash flow per share
-$0.19
Book value per share
$1.11
Revenue per share
$0.72
TBVPS
$1.09
Total assets
$37.11M
Total liabilities
$7.73M
Debt
$415,000
Equity
$29.37M
Working capital
$19.61M
Debt to equity
0.01
Current ratio
4.02
Quick ratio
3.73
Net debt/EBITDA
9.5
Margins
Efficiency
Dividend
EBITDA margin
-10.2%
Gross margin
86%
Net margin
-14.3%
Operating margin
-32.3%
Return on assets
-6.9%
Return on equity
-8.6%
Return on invested capital
-57.1%
Return on capital employed
-8.7%
Return on sales
-14.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICAD stock price
How has the Icad stock price performed over time
Intraday
3.39%
1 week
-6.15%
1 month
18.45%
1 year
10.91%
YTD
3.39%
QTD
16.93%
Financial performance
How have Icad's revenue and profit performed over time
Revenue
$18.94M
Gross profit
$16.29M
Operating income
-$6.12M
Net income
-$2.71M
Gross margin
86%
Net margin
-14.3%
The net margin has soared by 75% YoY but it has decreased by 18% from the previous quarter
The net income has soared by 73% YoY but it has contracted by 19% from the previous quarter
The operating margin has increased by 42% year-on-year but it has declined by 14% since the previous quarter
Icad's operating income has increased by 36% YoY but it has decreased by 15% from the previous quarter
Growth
What is Icad's growth rate over time
Valuation
What is Icad stock price valuation
P/E
N/A
P/B
1.65
P/S
2.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.59
The company's EPS has surged by 72% YoY but it fell by 22% QoQ
ICAD's price to book (P/B) is 71% lower than its 5-year quarterly average of 5.6 but 27% higher than its last 4 quarters average of 1.3
The equity has contracted by 5% YoY and by 5% from the previous quarter
ICAD's P/S is 50% below its 5-year quarterly average of 5.1 but 16% above its last 4 quarters average of 2.2
ICAD's revenue is up by 10% YoY
Efficiency
How efficient is Icad business performance
The company's return on sales has surged by 76% YoY but it fell by 18% QoQ
The ROE has soared by 73% YoY but it has contracted by 21% from the previous quarter
Icad's return on assets has surged by 67% YoY but it has decreased by 25% QoQ
ICAD's return on invested capital has surged by 52% year-on-year but it is down by 42% since the previous quarter
Dividends
What is ICAD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICAD.
Financial health
How did Icad financials performed over time
Icad's quick ratio has soared by 78% YoY but it has decreased by 4.8% from the previous quarter
The total liabilities has declined by 48% year-on-year and by 3.1% since the previous quarter
The debt is 99% less than the equity
The debt to equity has dropped by 50% since the previous quarter and by 50% year-on-year
The debt has decreased by 19% YoY and by 12% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.